Log In
Print this Print this

LymPro Test

  Manage Alerts
Collapse Summary General Information
Company Memory Dx LLC
DescriptionMeasure CD69 presentations at the surface in peripheral blood lymphocytes (PBLs) with and without mitogenic stimulation
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose chronic traumatic encephalopathy; Diagnose mild to moderate Alzheimer's disease (AD); Diagnose moderate and severe Alzheimer's disease (AD); Early diagnosis of Alzheimer's disease (AD)
Regulatory Designation


Amarantus BioScience Holdings Inc.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today